IsabelCArrillaga-RomanyMD

PubMed

• Clinical Reasoning: Assessing New Neurologic Deficits in Patients With Hematologic Malignancy on Bruton Tyrosine Kinase Inhibitor Therapy.
  Thomas A Nelson, Naina K Murthy, Maria Martinez-Lage Alvarez, Jeremy Abramson, Andrew R Branagan
  Neurology. 2024-11-12
• 2 citations
  Demonstrated efficacy and mechanisms of sensitivity of ONC201: H3K27M-mutant diffuse midline glioma in the spotlight.
  Isabel Arrillaga-Romany, Julie J Miller
  Neuro-Oncology. 2024-06-03
• 12 citations
  Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma.
  Avishay Spitzer, Simon Gritsch, Masashi Nomura, Alexander Jucht, Jerome Fortin
  Cancer Cell. 2024-05-13

Journal Articles

• Antiangiogenic Therapies for Glioblastoma  
  Arrillaga-Romany I, Norden A, CNS Oncology, 1/1/2014
• Neurologic complications of cancer drug therapies  
  Lee EQ, Arrillaga-Romany I, Wen PY, Continuum (Minneapolis Minn), 1/1/2012

Books/Book Chapters

• Controversies in Neuro-Oncology: Best Evidence Medicine for Brain Tumor Surgery. 
  Chapter: The Role of Adjuvant Therapy in Newly Diagnosed High Grade Astrocytoma. 
  Arrillaga-Romany I, Ahluwalia, MS, Wen PYEditors: Quinones-Hinojosa A, Raza SM.Thieme, New York, NY2014
• Neuro-oncology 
  Chapter: Diagnosis of Brain Tumors: Clinical and Radiographic 
  Arrillaga-Romany I, Lee EQ and Wen PYEditors: R. J. Packer and D. Schiff.Blackwell Publishing Ltd., Oxford, United KingdomEdition 1st,2012

Abstracts/Posters

• Newly Diagnosed Single Brain Mass - Implementation and performance of a hospital-wide management pathway.
  Isabel Arrillaga-Romany, Aneesh Singhal, Susann Jarhult, Corey Gill3, Aurelie Cordier, Benjamin White2, SooAe Jones, Michelle Pisapia, Daniel Cahill, William Curry, Jo..., Neurology; Annual Meeting of American Academy of Neurology, Washington, DC, 1/1/2015
• Structural Brain Changes in Patients Undergoing Autologous Stem Cell Transplantation for Lymphoma.
  Isabel Arrillaga-Romany, Kourosh Jafari-Khouzani, Yi-Bin Chen, Bruce Rosen, Tracy Batchelor, and Jorg Dietrich, Neurology; Annual Meeting of American Academy of Neurology, Washington, DC, 1/1/2015
• Eribulin induced neuropathy in a patient with previously undiagnosed Charcot-Marie-Tooth (CMT) disease.
  Arrillaga-Romany I, Ruddy KJ, Greenberg SA, Nayak L, Society for Neuro-Oncology, San Francisco, CA, 1/21/2013
• Stress, Strain and Sensorimotor Gating.
  Arrillaga-Romany I, and Hammer RP, Experimental Biology, San Francisco, CA, 1/1/2006
• Effects of Modafinil on Brain Regions Underlying Cognitive and Emotional Information Processing: An fMRI Study in Normal Healthy Volunteers.
  Arrillaga-Romany I, Mattay VS, Rasetti R, Alce A, Lazerow A, Premkumar A, Dean C, Goldberg T, Apud JS, Weinberger DR, Neuropsychopharmacology, 1/1/2006
• Corticotropin-releasing factor disrupts prepulse inhibition in the rat: The role of central CRF-1 and 2 receptors.
  Arrillaga-Romany IC, Hammer RP, New England Pharmacologists, 34th Annual Meeting, Portland, ME, 1/28/2005
• Is dopamine to blame for CRF-induced sensorimotor gating deficits in rats?
  Arrillaga-Romany I, Annual Meeting of the American College of Neuropsychopharmacology, Waikoloa, HI, 1/1/2005
• Corticotropin-releasing factor impairs sensorimotor gating in the Sprague Dawley rat: reversal by clozapine and raclopride.
  Arrillaga-Romany I, and Hammer RP, Neuropsychopharmacology, 1/1/2005
• Sensitivity of mesocorticolimbic areas to opiod receptor stimulation after repeated social defeat stress: Fos immunoreactivity in the nucleus. Program No. 357.7. 2004 ...
  Nikulina EM, Arrillaga-Romany I, Fanous S, Miczek KA, Hammer RP, Society for Neuroscience, Washington, DC, 1/1/2004
• The potentiation of morphine’s NMDA dependent antipruritic effect by micromolar concentrations of naltrexone: A potential therapy for pruritus and stereotypic behavior...
  Arrillaga-Romany I, New England Pharmacologists, 33rd Annual Meeting, Burlington, VT, 1/1/2003
• Long-term functional activation in amygdale induced by repeated social stress. Program No. 282.2. 2003 Abstract Viewer/Itinerary Planner.
  Nikulina EM, Covington HE, Arrillaga-Romany I, Miczek KA, Hammer RP, Society for Neuroscience, Washington, DC, 1/1/2003
• Join now to see all

Lectures

• Single agent ONC201 in adult recurrent H3 K27M-mutant glioma. 
  2019 ASCO Annual Meeting - 6/1/2019
• What's on the Horizon for Newly Diagnosed Glioblastoma 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
• Update on Central Nervous System Tumors 
  Harvard Medical School, Boston, MA - 1/1/2014
• Corticotropin-releasing factor disrupts prepulse inhibition in the rat: The role of central CRF-1 and 2 receptors. 
  Portland, ME - 1/1/2005
• Long term exposure to stress-levels of corticosterone does not produce sensorimotor gating deficits in rats. 
  Biddeford, ME - 1/1/2004
• Join now to see all

Other

• The Pharmacology of Corticotropin-releasing Factor (CRF): Effects on Sensorimotor Gating in the Rat. (Thesis) 
  Arrillaga-Romany, I, Boston: ProQuest
  1/1/2006